drugset / Trial / NCT03468348

Duloxetine for Acute Post-mastectomy Pain

NCT03468348

Completed 88 enrolled Assiut University
RandomizedParallel-groupDouble-blindTreatment

Summary

The objective of this study is to evaluate the analgesic effect of oral dulexitine tablet (administered 2 h before surgery) as well as the ideal dose for acute postmastectomy pain.

Timeline

Start
2018-04-01
Primary completion
2020-02-10
Completion
2020-02-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Duloxetine Small molecule 30 mg Oral
Comparator Duloxetine Small molecule 60 mg Oral
Comparator Duloxetine Small molecule 90 mg Oral

Indications

No indication recorded.